We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.
TODAY'S HIGH
711.45
TODAY'S LOW
699.05
52 WEEK HIGH
1168
52 WEEK LOW
668.85
% of Shares Held by
All Insider
45.22%
% of Shares Held by
Institutions
21.27%
% of Float Held by
Institutions
38.82%
Number of Institutions
Holding Shares
76
MARKET CAP
25404.55 Cr.
ETERPRISE VALUE
26799.93 Cr.
NO. OF SHARES
36.25 Cr.
BOOK VALUE
163.027
DIV. YIELD
1%
DEBT
2217.62 Cr.
GROSS PROFIT
3706.14 Cr.
CASH
256.83 Cr.
REVENUE
6999.95 Cr.
REVENUE/SHARE
193.1
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | -7.82 Cr. | 1.29 Cr. | -6.07 Cr. |
| Change To Liabilities | -109.59 Cr. | 128.78 Cr. | 358.81 Cr. | 128.79 Cr. |
| Total cashflows from Investing Activities | -1305.48 Cr. | -1322.14 Cr. | -1124.06 Cr. | -797 Cr. |
| Net Borrowings | -266.28 Cr. | 745.92 Cr. | -303.15 Cr. | 318.06 Cr. |
| Total Cash from Financing Activities | 679.24 Cr. | 614.46 Cr. | -534.91 Cr. | 832.93 Cr. |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Assets | 1186.69 Cr. | 1186.69 Cr. | 1186.69 Cr. | 741.40 Cr. |
| Net Income | 1307.19 Cr. | 523.47 Cr. | 536.08 Cr. | 491.73 Cr. |
| Change in Cash | -155.48 Cr. | 165.03 Cr. | -556.91 Cr. | 772.13 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 470.76 Cr. | 872.71 Cr. | 1102.06 Cr. | 736.20 Cr. |
| Depreciation | 288.52 Cr. | 230.49 Cr. | 184.81 Cr. | 162.28 Cr. |
| Other Cashflows from Investing Activities | 57 Lakhs | 7 Lakhs | 15 Lakhs | 8 Lakhs |
| Dividends Paid | -126.88 Cr. | -45.09 Cr. | -106.38 Cr. | -43.99 Cr. |
| Change to Inventory | -475.65 Cr. | -111 Cr. | -63.90 Cr. | -74.33 Cr. |
| Change to Account Receivables | -600.56 Cr. | -25.01 Cr. | -4.69 Cr. | -153.61 Cr. |
| Other Cashflows from Financing Activities | -114.29 Cr. | -86.37 Cr. | -125.38 Cr. | -182.54 Cr. |
| Change to Net Income | 60.85 Cr. | 125.58 Cr. | 90.55 Cr. | 180.94 Cr. |
| Capital Expenditures | -1306.57 Cr. | -1314.82 Cr. | -1153.29 Cr. | -793.61 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 1526.80 Cr. | 664.55 Cr. | 676.18 Cr. | 621.97 Cr. |
| Minority Interest | 72 Lakhs | 12.24 Cr. | 94.62 Cr. | 83.95 Cr. |
| Net Income | 1640.29 Cr. | 750.64 Cr. | 792.20 Cr. | 802.48 Cr. |
| Selling General Administrative | 442.08 Cr. | 386.10 Cr. | 322.24 Cr. | 259.48 Cr. |
| Gross Profit | 3706.14 Cr. | 2263.03 Cr. | 2018.21 Cr. | 1912.01 Cr. |
| Ebit | 1640.29 Cr. | 750.64 Cr. | 792.20 Cr. | 802.48 Cr. |
| Operating Income | 1640.29 Cr. | 750.64 Cr. | 792.20 Cr. | 802.48 Cr. |
| Other Operating Expenses | 1335.25 Cr. | 895.40 Cr. | 718.56 Cr. | 687.37 Cr. |
| Interest Expense | -100.62 Cr. | -76.71 Cr. | -115.35 Cr. | -174.90 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 219.38 Cr. | 129.33 Cr. | 129.42 Cr. | 117.80 Cr. |
| Total Revenue | 6999.96 Cr. | 4506.10 Cr. | 4186.31 Cr. | 4167.56 Cr. |
| Total Operating Expenses | 5359.67 Cr. | 3755.46 Cr. | 3394.11 Cr. | 3365.08 Cr. |
| Cost of Revenue | 3293.82 Cr. | 2243.07 Cr. | 2168.10 Cr. | 2255.55 Cr. |
| Total Other Income Expense Net | -113.49 Cr. | -86.09 Cr. | -116.02 Cr. | -180.51 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 1307.42 Cr. | 535.22 Cr. | 546.76 Cr. | 504.17 Cr. |
| Net Income Applicable to Common Shares | 1307.19 Cr. | 523.47 Cr. | 536.08 Cr. | 491.73 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 19 Lakhs | 10 Lakhs | 50 Lakhs | 90 Lakhs |
| Capital Surplus | 0 | 697.70 Cr. | 697.49 Cr. | 740.09 Cr. |
| Total Liabilities | 3757.62 Cr. | 4126.54 Cr. | 3259.11 Cr. | 3143.22 Cr. |
| Stock Holder Equity | 5914.46 Cr. | 3502.90 Cr. | 2978.77 Cr. | 2630.77 Cr. |
| Minority Interest | 72 Lakhs | 12.24 Cr. | 94.62 Cr. | 83.95 Cr. |
| Other Liabilities | 559.66 Cr. | 204.42 Cr. | 7.76 Cr. | 13.99 Cr. |
| Total Assets | 9672.80 Cr. | 7641.68 Cr. | 6332.50 Cr. | 5857.94 Cr. |
| Common Stock | 181.25 Cr. | 87.12 Cr. | 87.12 Cr. | 43.33 Cr. |
| Retained Earnings | 0 | 2705.08 Cr. | 2148.53 Cr. | 1702.55 Cr. |
| Other Liabilities | 490.26 Cr. | 445.23 Cr. | 740.70 Cr. | 396.25 Cr. |
| Good Will | 0 | 0 | 42 Lakhs | 42 Lakhs |
| Treasury Stock | 5733.21 Cr. | 13 Cr. | 45.63 Cr. | 144.80 Cr. |
| Other Assets | 417.66 Cr. | 320.07 Cr. | 404.49 Cr. | 306.43 Cr. |
| Cash | 256.84 Cr. | 412.32 Cr. | 247.29 Cr. | 804.20 Cr. |
| Current Liabilities | 2336.95 Cr. | 2400.14 Cr. | 1916.37 Cr. | 1932.17 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 0 | 351.72 Cr. | 287.43 Cr. | 295.45 Cr. |
| Other Stockholder Equity | 5733.21 Cr. | 13 Cr. | 45.63 Cr. | 144.80 Cr. |
| Property Plant Equipment | 5908.12 Cr. | 4890.39 Cr. | 3885.21 Cr. | 2939.92 Cr. |
| Total Cur. Assets | 3273.70 Cr. | 2367.60 Cr. | 2004.87 Cr. | 2577.11 Cr. |
| Long Term Investments | 73.13 Cr. | 63.52 Cr. | 37.01 Cr. | 33.16 Cr. |
| Net Tangible Assets | 5914.27 Cr. | 3502.80 Cr. | 2977.85 Cr. | 2629.45 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 1390.50 Cr. | 825.93 Cr. | 789.87 Cr. | 880.03 Cr. |
| Long Term Debt | 930.41 Cr. | 1268.05 Cr. | 580.84 Cr. | 814.80 Cr. |
| Inventory | 1411.33 Cr. | 935.68 Cr. | 835.68 Cr. | 771.79 Cr. |
| Accounts Payable | 490.08 Cr. | 576.33 Cr. | 345.16 Cr. | 279.28 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account